Search

Search Results

• 

  New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

  Mehrie H. Patel, Alok A. Khorana

  16-05-2024

  https://doi.org/10.4081/btvb.2024.113

  465

  PDF: 227
• 

  Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

  Sarah Gallitto, Thomas C. Varkey, Jacob Lahti

  13-12-2024

  https://doi.org/10.4081/btvb.2024.131

  990

  PDF: 152
• 

  Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

  Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

  22-03-2022

  https://doi.org/10.4081/btvb.2022.10

  1021

  PDF: 325

  APPENDIX: 65
• 

  Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

  Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

  16-05-2024

  https://doi.org/10.4081/btvb.2024.114

  466

  PDF: 173
• 

  Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

  Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni

  03-11-2022

  https://doi.org/10.4081/btvb.2022.42

  838

  PDF: 278
• 

  Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

  Agnes Y.Y. Lee

  29-02-2024

  https://doi.org/10.4081/btvb.2024.111

  1429

  PDF: 303
• 

  Venous thromboembolism and mortality in patients with hematological malignancies

  Kristen M. Sanfilippo, Tzu-Fei Wang

  16-05-2024

  https://doi.org/10.4081/btvb.2024.119

  619

  PDF: 222
• 

  Circulating albumin-to-fibrinogen ratio may be a risk indicator for venous thromboembolism: findings from a population-based prospective cohort study

  Setor K. Kunutsor, Sudhir Kurl, Ari Voutilainen, Jari Laukkanen

  14-07-2022

  https://doi.org/10.4081/btvb.2022.36

  1017

  PDF: 219
• 

  Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

  Paolo Prandoni, Franca Bilora, Raffaele Pesavento, Giorgina Salgueiro, Angeles Blanco-Molina, Raquel Lòpez-Reyes, Manuel Monreal, and the RIETE Investigators

  23-05-2022

  https://doi.org/10.4081/btvb.2022.28

  5180

  PDF: 441

  APPENDIX: 116
• 

  Cancer-associated ischemic stroke: current knowledge and future directions

  Ronda Lun, Deborah M. Siegal

  16-05-2024

  https://doi.org/10.4081/btvb.2024.117

  1747

  PDF: 441
• 

  Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

  Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci

  14-12-2022

  https://doi.org/10.4081/btvb.2022.50

  779

  PDF: 302
• 

  Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot

  Rushad Patell, Jeffrey I. Zwicker, Rohan Singh, Simon Mantha

  16-05-2024

  https://doi.org/10.4081/btvb.2024.123

  1240

  PDF: 287
• 

  Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

  Ang Li, Emily Zhou

  16-05-2024

  https://doi.org/10.4081/btvb.2024.108

  644

  PDF: 255
• 

  Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

  Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

  16-05-2024

  https://doi.org/10.4081/btvb.2024.118

  714

  PDF: 287
• 

  It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders

  Marialaura Bonaccio, Licia Iacoviello, Maria Benedetta Donati

  03-08-2023

  https://doi.org/10.4081/btvb.2023.91

  1087

  PDF: 209
• 

  Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

  Marco P. Donadini, Walter Ageno

  15-04-2022

  https://doi.org/10.4081/btvb.2022.22

  1995

  PDF: 523
• 

  Aspirin or low-molecular weight heparin for thromboprophylaxis after a fracture? That is the question

  Giuseppe Camporese, Paolo Prandoni, Walter Ageno

  17-05-2023

  https://doi.org/10.4081/btvb.2023.82

  729

  PDF: 367
• 

  Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma

  Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth

  16-05-2024

  https://doi.org/10.4081/btvb.2024.115

  624

  PDF: 205
• 

  Distal deep vein thrombosis: is there a way out of this dark forest?

  Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini

  04-09-2024

  https://doi.org/10.4081/btvb.2024.129

  667

  PDF: 208
• 

  Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis

  Maria J. Fernandez Turizo, Rushad Patell, Jeffrey I. Zwicker

  16-05-2024

  https://doi.org/10.4081/btvb.2024.120

  698

  PDF: 306
• 

  Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know

  Giovanni Tiscia, Elvira Grandone

  13-09-2022

  https://doi.org/10.4081/btvb.2022.43

  2181

  PDF: 246
• 

  From rare to aware: confronting Lemierre syndrome

  Silvia Cardi, Filippo Catalani, Luca Valerio, Stefano Barco

  21-10-2024

  https://doi.org/10.4081/btvb.2024.147

  1676

  PDF: 344